Physician profile
Michael D Kim
NPI 1427002179
$865.88
in general payments reported to CMS, 2019-2025
12 companies · $18.14 in 2025
The $18.14 reported for 2025 was less than what a typical Addiction Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $170 · 2021: $65.91 · 2023: $85.49 · 2025: $18.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $85.49 · Food and Beverage: $18.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $85.49 |
| Food and Beverage | $18.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $323.85 | 2019-2021 | |
| Medtronic USA, INC. | $140.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $123.55 | 2019-2023 | |
| Stryker Corporation | $100.21 | 2019 | |
| Emd Serono, INC. | $72.00 | 2019-2020 | |
| Pfizer INC. | $31.82 | 2019-2025 | |
| Genzyme Corporation | $16.84 | 2019 | |
| Acorda Therapeutics, INC | $16.23 | 2019 | |
| Eisai INC. | $15.96 | 2021 | |
| Greenwich Biosciences, INC. | $13.95 | 2020 | |
| Mdd US Operations, LLC | $11.10 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.